Predictors of ICS/LABA prescribing in COPD patients: a study from general practice

BACKGROUND: A combination of inhaled corticosteroid and long-acting beta(2) agonist (ICS/LABA) is used frequently to treat chronic obstructive pulmonary disease (COPD) patients. The aim of the study was to determine whether prescribing ICS/LABA to COPD patients in primary care in 2009/10 was within...

Descripción completa

Detalles Bibliográficos
Autores principales: Drivenes, Elin, Østrem, Anders, Melbye, Hasse
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3983887/
https://www.ncbi.nlm.nih.gov/pubmed/24597538
http://dx.doi.org/10.1186/1471-2296-15-42

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3983887/
https://www.ncbi.nlm.nih.gov/pubmed/24597538
http://dx.doi.org/10.1186/1471-2296-15-42

Ejemplares similares